The verified answer
As of Oct 2026, DEPLOY verifies B-TEMIA: 1 model, 1 deployment across 1 region. 3 sources back the record.
CategoryExoskeletons
Overview
Canadian bio-robotics company developing Dermoskeleton™ technology for human mobility augmentation. Its flagship product Keeogo is a powered lower-limb exoskeleton that provides motorized knee assistance for stroke patients and individuals with mobility impairments in rehabilitation settings. B-TEMIA received FDA 510(k) clearance for Keeogo in September 2020 and was acquired by Wistron Medical Tech Holding Company in 2025 through a court-approved stalking horse agreement following insolvency proceedings
Verified record
- Verified deployments
- 1 deployment on file
- Active incidents
- None on file
Key facts
HQ
Founded
Leadership
Product
FDA
Funding (reported, unconfirmed)
Acquisition (reported, 2025)
US distribution (reported, May 2024)
Data & sources
Web sources
3
3 sources backing this record.View all →
Models (1)
View all models →Partnerships
Every company B-TEMIA has built with, alongside the ones only announced in a press release.
Most-frequent partners
- 1DIH Holding1× joint1 total
- 2Nasdaq1× joint1 total
Most recent
- B-TEMIA x DIH Holding2024-05-28with DIH Holdingjust announced
B-TEMIA on the deployment map
View the global map1 verified deployment across 1 region, newest verified Jun 2024. Explore where B-TEMIA's robots are operating, by place and type.
View the full B-TEMIA deployment record →
Relationships
Founders (1)
- Stephane Bedardcofounderno longer at company
Former / Previously (2)
- David Quitman CEOsecondary-verified
- Stephane Bedard Founder, President & CEO (Jan 2010 – Sep 2023)reported, not verified
Safety record
No incidents on record for B-TEMIA.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- B-TEMIA1 deployment
Recent coverage
B-TEMIA in third-party press
Peers
26 peers across 1 segment. Every B-TEMIA competitor derived from shared form-factor and application-domain edges.
exoskeleton(26)
23 companies in this segment · highly_concentrated (HHI 5009.45179584121) · leader Hypershell at 5217%
- ATOUNdirect competitor(inferred)moderate
- Againer Skidirect competitor(inferred)moderate
- Bionik Laboratoriesdirect competitor(inferred)moderate
- Cyberdynedirect competitor(inferred)moderate
- Daiya Industry Co., Ltd.direct competitor(inferred)moderate
- Ekso Bionicsdirect competitor(inferred)moderate
Mentioned on (4)
Registry pages whose text names B-TEMIA.
Companies (1)
Robots and products (1)
People (2)
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- early
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships
2 total · 2 just announced
Every company B-TEMIA has built with, alongside the ones only announced in a press release.
Most recent
- B-TEMIA x DIH Holding2024-05-28with DIH Holdingjust announced
Most-frequent partners
- 1DIH Holding1× joint1 total
- 2Nasdaq1× joint1 total
Funding rounds (1)
- Series A2015-05-05
Investors: Epic Capital Management (lead)
Timeline
Every recorded move in B-TEMIA’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
Funding roundSeries A funding round
2015-05-05Series A
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Verified media addedVerifiedJun 11, 2026
B-TEMIA unveils Keeogo™
- Verified media addedVerifiedJun 11, 2026
B-TEMIA unveils Keeogo™| Regaining the power to walk with Parkinson's
- Record createdJun 6, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
B-TEMIA Keeogo at Montreal
Sources (3)
Common questions
What is B-TEMIA?
What does B-TEMIA make?
Is B-TEMIA publicly traded?
Who competes with B-TEMIA?
Who is the CEO of B-TEMIA?
How can I invest in B-TEMIA?
Where is B-TEMIA headquartered?
Who owns B-TEMIA?
Where does B-TEMIA operate robots?
How many robots has B-TEMIA deployed?
Is B-TEMIA a top robotics company?
When was B-TEMIA founded?
Is B-TEMIA safe?
Methodology: Verified · 3 sources (no primary) · last reviewed 2026-10-12
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-10-12
Sources by quality tier
- 3
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for B-TEMIA.Peer companies
- Gobio Robot6 models
- Fourier Intelligence4 models
- Honda4 models
- Lifeward3 models
- Lockheed Martin3 models
- Wandercraft3 models
In the press
Recent coverage mentioning B-TEMIA from third-party publications. Automatically surfaced; not part of the verified registry record.
B-Temia Inc. — PwC Canada Insolvency Proceedings
PwC Canada reports B-TEMIA filed Notice of Intention to Make a Proposal (Dec 2024), emerged from insolvency proceedings as a solvent entity in April 2025 following Wistron Medical…
DIH Holding US, Inc. Announces Strategic Partnership with B-Temia Inc. to Revolutionize the Rehabilitation Market
DIH Holding US announces strategic partnership with B-TEMIA giving DIH exclusive rights to market and sell Keeogo in Canada, US, and Mexico
B-Temia gains commercial access to Taiwan for human mobility device
B-Temia Asia obtained Taiwan Food & Drug Administration (TFDA) product license for its Keeogo Dermoskeleton human mobility device.
B-Temia Inc. Obtains 510(k) Clearance for Keeogo from the USA Food & Drug Administration (FDA)
B-TEMIA receives FDA 510(k) clearance for its Keeogo Dermoskeleton powered human mobility device, opening the US medical device market
B-Temia wins FDA clearance for mobility exoskeleton
MassDevice covers B-TEMIA's FDA 510(k) clearance for its Keeogo Dermoskeleton system for stroke patient rehabilitation
B-TEMIA announces closing of financing with Epic Capital Management
B-TEMIA closes private placement with Epic Capital Management and Canadian private investors, confirming 60% increase in company value
Machine-readable surfaces
- Markdown mirror: /companies/b-temia.md
- RSS feed: /companies/b-temia/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/af791bbb-c3b4-4628-bfe7-8404c754dd09
- Revision history: /companies/b-temia/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Gobio Robot6 models
- Fourier Intelligence4 models
- Honda4 models
- Lifeward3 models
- Lockheed Martin3 models
- Wandercraft3 models
Video
B-TEMIA unveils Keeogo™, the latest in human augmentation systems designed to help individuals walk more and walk better. Jean-Maurice was diagnosed with Parki
Julia, a University School student in Hamilton, Ontario, sustained a stroke in 2013, which affected her mobility on the left side of her body resulting in limit
The Center for Human Performance Optimization is dedicated to creating an inviting atmosphere to support and improve mobility in children and adolescents with p
B-TEMIA unveils Keeogo™, the latest in human augmentation systems designed to help individuals walk more and walk better. Luc has severe hip osteoarthritis. Ke
B-TEMIA unveils Keeogo™, the latest in human augmentation systems designed to help individuals walk more and walk better. Étienne lives with secondary progress
B-TEMIA unveils Keeogo™, the latest in human augmentation systems designed to help individuals walk more and walk better. Claude has severe knee osteoarthritis
Restoring the Ability to Walk with Robotics. Dermoskeleton which is lightweight and flexible, providing safe and customised active training. The smart motorize
B-TEMIA dévoile Keeogo™, le dernier cri en systèmes d’augmentation de l’humain (human augmentation systems) conçu pour aider les individus à marcher plus et mie
Keeogo is an ambulatory assistive device that is fitted to the lower body, and is powered at the knee. This computer-controlled orthosis provides complementary
Heat Index
Serious54/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
B-TEMIA draws attention at the 49th percentile but verifies reality at the 14th percentile among exoskeletons. Hype Gap +35.4, 9th widest among exoskeletons.
6-month trend
Analysis
Clean safety record across 1 verified deployment. Funding runway warrants monitoring: last known round 139 months ago.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Oct 19, 2026